Home/Filings/4/0001615774-18-001627
4//SEC Filing

Richtarich Thomas Philip 4

Accession 0001615774-18-001627

CIK 0000102198other

Filed

Mar 5, 7:00 PM ET

Accepted

Mar 6, 1:11 PM ET

Size

4.8 KB

Accession

0001615774-18-001627

Insider Transaction Report

Form 4
Period: 2018-02-12
Richtarich Thomas Philip
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2018-02-12$0.09/sh+333,333$30,000333,333 total
Footnotes (1)
  • [F1]A bonus of $30,000 to be paid in Common Stock was granted on 5/1/2017. The closing stock price on 5/1/2017 was $0.09

Documents

1 file

Issuer

CALMARE THERAPEUTICS Inc

CIK 0000102198

Entity typeother

Related Parties

1
  • filerCIK 0001732857

Filing Metadata

Form type
4
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 1:11 PM ET
Size
4.8 KB